Drug Trial Radar · NCT02715115
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
Last checked: Nov 19, 2026Latest source record: Aug 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
82
Actual
Start
Mar 2016
Primary completion
Jan 5, 2017
Study completion Jan 5, 2017
Sponsor
- Lead sponsor
- Neuren Pharmaceuticals LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- rettsyndrome.org
- First posted
- Mar 22, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 5 years, up to 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Rett syndrome in children and adolescents.
Conditions
- Rett Syndrome
Interventions
NNZ-2566Drug
Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.
PlaceboDrug
Strawberry flavored solution and Water for Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Through study completion, an average of 11 weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
UCSF Benioff Children's Hospital Oakland
Oakland, California
University of California, San Diego
San Diego, California
Children's Hosptial Colorado
Aurora, Colorado
Rush University Medical Center
Chicago, Illinois
Boston Children's Hospital
Boston, Massachusetts
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Greenwood Genetic Center
Greenwood, South Carolina
Vanderbilt University
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.